Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Latest Advances in
Transverse Myelitis
Overview
Find a Doctor
Latest Advances
Clinical Trials
Latest Advances
Condition:
Neuromyelitis Optica
Journal:
Folia medica
Treatment Used:
Intravenous Gamma Globulin
Number of Patients:
1
Published —
January 08, 2021
The study researched the outcomes of intravenous gamma globulin in treating neuromyelitis optica.
Condition:
Pregnancy in Neuroimmunologic Disorders
Journal:
Neurology(R) neuroimmunology & neuroinflammation
Treatment Used:
Rituximab (RTX)/Ocrelizumab (OCR)
Number of Patients:
81
Published —
December 18, 2020
The study researched the outcomes of rituximab (RTX)/ocrelizumab (OCR) in women who are pregnant with neuroimmunologic disorders.
Condition:
Bilateral ARCO Stage II Steroid-Associated Osteonecrosis of the Femoral Head
Journal:
Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc
Treatment Used:
Repetitive 1.6 ATA Hyperbaric Oxygen Therapy
Number of Patients:
1
Published —
November 23, 2020
This study presented a case of a 36-year-old female diagnosed with bilateral early stage ARCO stage II steroid-associated osteonecrosis (SAON) caused by steroid therapy for neuromyelitis optica spectrum disorder (NMOSD) who was treated with repetitive 1.6 ATA hyperbaric oxygen (HBO2) therapy.
Condition:
Patients with Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder and Myasthenia Gravis during the COVID-19 Pandemic
Journal:
Brain and nerve = Shinkei kenkyu no shinpo
Treatment Used:
Continuing Current Immunotherapy Treatment
Number of Patients:
0
Published —
October 14, 2020
This article discusses the treatment of patients with multiple sclerosis, neuromyelitis optica spectrum disorders, and myasthenia gravis during the COVID-19 pandemic.
Condition:
Neuromyelitis Optica Spectrum Disorders
Journal:
Scientific reports
Treatment Used:
Mycophenolate Mofetil Therapy
Number of Patients:
1047
Published —
October 08, 2020
The study researched the outcomes of mycophenolate mofetil therapy for patients with neuromyelitis optica spectrum disorders.
Condition:
Neuromyelitis Optica Spectrum Disorder (NMOSD) During the COVID-19 Pandemic
Journal:
Therapeutics and clinical risk management
Treatment Used:
Disease-Modifying Therapies (DMTs)
Number of Patients:
0
Published —
September 05, 2020
This study examined neuromyelitis optica spectrum disorder (NMOSD) disease-modifying therapies (DMTs) during the COVID-19 pandemic.
Condition:
Dual Spinal Cord Injury with Transverse Myelitis
Journal:
Spinal cord series and cases
Treatment Used:
Clinical Management
Number of Patients:
1
Published —
August 26, 2020
This case report describes a patient with a dual spinal cord injury that later contracted transverse myelitis.
Condition:
Recurrent Optic Neuritis Associated with Aquaporin (AQP) 4 Antibody Seropositive Neuromyelitis Optica (NMO-ON)
Journal:
[Zhonghua yan ke za zhi] Chinese journal of ophthalmology
Treatment Used:
Intravenous Methylprednisolone Pulse (IVMP) Therapy
Number of Patients:
35
Published —
August 26, 2020
This study observed the effects of intravenous methylprednisolone pulse (IVMP) therapy on the recovery of visual acuity and its influencing factors in patients with the relapse of aquaporin (AQP) 4 antibody positive neuromyelitis optica related optic neuritis (NMO-ON).
Condition:
Neuromyelitis Optica Spectrum Disorder
Journal:
Neurology(R) neuroimmunology & neuroinflammation
Treatment Used:
Inhibition of IL-6 Activity
Number of Patients:
0
Published —
August 22, 2020
The study researched the outcomes of inhibition of IL-6 activity in patients with neuromyelitis optica spectrum disorder.
Condition:
Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
Journal:
Scientific reports
Treatment Used:
Disease Modifying Drugs
Number of Patients:
62
Published —
August 19, 2020
The study researched patterns of neurological disability in multiple sclerosis and neuromyelitis optica spectrum disorders.
Condition:
Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)
Journal:
Neurology(R) neuroimmunology & neuroinflammation
Treatment Used:
Disease-Modifying Therapy
Number of Patients:
67
Published —
August 01, 2020
This study tested the safety and efficacy of using azathioprine, mycophenolate mofetil, or rituximab to treat patients with aquaporin-4 antibody-positive NMOSD.
Condition:
Central Nervous System Demyelinating Diseases During the Coronavirus Disease 2019 Pandemic
Journal:
Arquivos de neuro-psiquiatria
Treatment Used:
Management Strategies
Number of Patients:
0
Published —
July 02, 2020
This article discusses management of central nervous system demyelinating diseases during the coronavirus disease 2019 pandemic.
Showing 1-12 of 48
Next